Utilizes modular microwave-powered radiofrequency (qRF) technology to accelerate the lyophilization process for parenteral pharmaceuticals, biologics, medical devices, tissues, and diagnostic reagents. This method reduces drying time from days or weeks to hours, improves uniformity and energy efficiency, and enables seamless scalability from laboratory to commercial production.
Funding
Funding not disclosed
Founders
Product
Problem
The traditional pharmaceutical freeze-drying process, or lyophilization, is slow, often taking days or weeks to complete, and can suffer from uneven drying, leading to inconsistent product quality. This lengthy process increases manufacturing costs and can limit the availability of critical medications and biologics.
Solution
LyoWave utilizes modular, microwave-powered radiofrequency (qRF) technology to accelerate the lyophilization process for parenteral pharmaceuticals, biologics, medical devices, tissues, and diagnostic reagents. This technology significantly reduces drying time from days or weeks to hours by ensuring faster and more uniform heating. The qRF technology offers precise product temperature control and is compatible with freeze-drying systems ranging from bench-top to production scale, enabling seamless scalability from laboratory to commercial production.
Target Audience
LyoWave's primary customers are pharmaceutical manufacturers, biotechnology companies, and medical device companies that utilize freeze-drying in their production processes.
Features
- Modular microwave-powered radiofrequency (qRF) technology for accelerated freeze-drying
- Improved drying rate and uniformity compared to traditional methods
- Precise product temperature control during lyophilization
- Compatible with various freeze-drying systems, from bench-top to production scale
- Seamless scalability from laboratory to pilot or commercial production
- Energy-efficient process compared to conventional freeze-drying